ReviewVaccines2026

Hidden Targets in Cancer Immunotherapy: The Potential of "Dark Matter" Neoantigens.

Francois Xavier Rwandamuriye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.